Phase 1 Safety and Immunogenicity of Meningococcal Vaccine

Clinical trial NCT00678652 · COMPLETED

Trial details

NCT number: NCT00678652
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Meningococcal Infection, Group B

Start date: 2008-04-01
Primary completion: 2009-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.